Page last updated: 2024-09-04

pomalidomide and clarithromycin

pomalidomide has been researched along with clarithromycin in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(clarithromycin)
Trials
(clarithromycin)
Recent Studies (post-2010) (clarithromycin)
6231215527,1491,6062,504

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)clarithromycin (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)5.5
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.3113
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.0903

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, A; Coleman, M; Forsberg, PA; Jayabalan, D; Mark, TM; Niesvizky, R; Pearse, RN; Pekle, KA; Perry, A; Rossi, AC; Tegnestam, L1

Trials

1 trial(s) available for pomalidomide and clarithromycin

ArticleYear
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.
    Blood advances, 2019, 02-26, Volume: 3, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Survival Analysis; Thalidomide; Treatment Outcome

2019